R & d- medical: biomedical (applied research/exploratory development)

Ended Awarded Last action

Contract number
75N94018F00004
Awardee
Awarding agency
Obligated
$1,088,133

Award facts

Contract value 100% obligated
$1,088,132.64 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 8 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Davis, CA, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00009 $0
Other Administrative Action P00008 $8,749
Funding Only Action P00007 $35,949
Supplemental Agreement for work within scope P00006 · Nichd: r & d: to evaluate in obese and non-obese women the pharmacokinetics and the pharmacodymanic effects, cycle control, and safety of levonorgestrel… $0
Funding Only Action P00005 $170,681
Change Order P00004 $210,865
Change Order P00003 $103,109
Funding Only Action P00002 $125,855
Change Order P00001 · To evaluate in obese and non-obese women the pharmacokinetics and the pharmacodymanic effects, cycle control, and safety of levonorgestrel butanoate (LB)… $175,964
Original award $256,961

About this award

The National Institute of Child Health and Human Development (NICHD) awarded a delivery order valued at $1.09 million to the University of California, Davis to support the Contraceptive Clinical Trials Network—Female Sites initiative. This Cost No Fee contract, awarded on September 25, 2018 with completion targeted for July 14, 2026, funds applied research and exploratory development activities to evaluate the pharmacokinetics, pharmacodynamics, cycle control, and safety of levonorgestrel butanoate (LB), a long-acting injectable contraceptive formulation, in both obese and non-obese women. The work will be performed at UC Davis's Davis, California campus and represents a non-severable requirement with no small business set-aside designation.

UC Davis, a premier public land-grant research institution with established expertise in biomedical research, brings substantial scientific and clinical capabilities to this initiative. As a major federal research partner with active SAM.gov registration and demonstrated contracting history extending back to 2001, the university maintains sophisticated research infrastructure and a track record of delivering complex clinical and laboratory research services across multiple NIH institutes. This delivery order leverages UC Davis's existing clinical research capabilities and infrastructure to advance NICHD's contraceptive research mission through rigorous evaluation of an alternative hormonal contraceptive option.

Quick answers

Who was awarded contract 75N94018F00004?

75N94018F00004 was awarded to University Of California, Davis by National Institute of Child Health and Human Development (National Institutes of Health) on September 25, 2018.

How much is contract 75N94018F00004 worth?

The government has obligated $1,088,133 on 75N94018F00004.

Is contract 75N94018F00004 an order under another contract?

Yes. 75N94018F00004 is a delivery order under HHSN275201300021I, an indefinite delivery contract.

Was contract 75N94018F00004 competed?

The extent of competition for 75N94018F00004 was full and open competition. The government received 8 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award